VASO Financials 07/16/2014 16:43:25 Vasomedical,

VASO Financials 07/16/2014 16:43:25
Vasomedical, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Jun 30, 2011
Total Revenue 32,890 29,240 23,489 16,373
Cost of Revenue 10,377 8,646 6,733 5,461
Gross Profit 22,513 20,594 16,756 10,912
Operating Expenses
Research and Development 689 576 324 462
Sales, General and Admin. 23,114 23,526 11,243 14,383
Non-Recurring Items - - - -
Other - - - -
Operating Income (1,290) (3,508) 5,189 (3,933)
Income From Continuing Operations
Add'l Income/Expense Items - 31 208 81
Earnings Before Interest and Tax (1,203) (3,329) 5,397 (3,852)
Interest Expense - - 9 32
Earnings Before Tax (1,203) (3,329) 5,388 (3,884)
Income Tax (58) 52 276 7
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (1,145) (3,381) 5,112 (3,891)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (1,145) (3,381) 5,112 (3,891)
Preferred Stock and Other Adjustments - - (1,221) (429)
Net Income Applicable to Common Shareholders (1,145) (3,381) 3,891 (4,320)